IMARC Group has recently released a new research study titled “United States Dialysis Market Report by Type, Product and Services, End User, and Region, 2026-2034,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

United States Dialysis Market Size, Growth, and Forecast (2026-2034)

The united states dialysis market size reached USD 31,073.9 Million in 2025 and is projected to reach USD 44,117.0 Million by 2034, growing at a CAGR of 3.97% during 2026-2034. The increasing prevalence of chronic kidney disease (CKD), recent technological innovation in dialysis machines, increasing healthcare funding and insurance coverage, and growing preference for home dialysis are the primary factors driving the u.s. dialysis market.

Dialysis refers to a medical procedure that substitutes the natural function of the kidneys by removing waste products and excess fluids from the blood. It includes hemodialysis, which uses a machine and a filter to clean the blood, and peritoneal dialysis, where the blood is cleaned inside the body using a fluid that absorbs waste. Dialysis aids in alleviating symptoms associated with kidney failure and provides several benefits, including improving quality of life and extending life expectancy.

Kidney failure remains a significant public health burden in the country. According to the National Forum of ESRD Networks, as of March 2025, dialysis facilities across the United States were treating 516,837 patients on dialysis, of whom 433,396 received in-center hemodialysis and 78,407 received dialysis at home. This raises a common question, how many people are on dialysis in the united states, underscoring the scale of demand that continues to support the u.s. dialysis market.

Explore Growth Opportunities in the United States Dialysis Market - Grab Your Sample Report for Evaluation: https://www.imarcgroup.com/united-states-dialysis-market/requestsample

Key Trends Driving the United States Dialysis Market

• Rising prevalence of chronic kidney disease: The increasing prevalence of chronic kidney disease (CKD) among the U.S. population, driven by higher rates of diabetes and hypertension, is propelling market growth. With hundreds of thousands of patients dependent on dialysis facilities nationwide, the question of how many people are on dialysis in the united states continues to draw attention from policymakers, providers, and researchers tracking the scale of kidney failure treatment.
• Technological innovation in dialysis machines: Recent advancements in dialysis machines and techniques are enhancing treatment efficacy and patient comfort. The development of portable dialysis machines catering to patients' need for mobility, along with the integration of artificial intelligence (AI) and machine learning (ML) to optimize treatment and predict complications, is supporting the u.s. dialysis market.
• Increasing healthcare funding and insurance coverage: Growing healthcare funding and insurance coverage for dialysis treatment, alongside supportive federal and state initiatives to improve kidney care infrastructure and accessibility, are bolstering market growth. The heightened awareness of kidney disease is also leading to earlier diagnosis and treatment.
• Growing preference for home dialysis: The growing preference for home dialysis due to its convenience and comfort is favoring market growth. Providers are expanding home hemodialysis and peritoneal dialysis programs, supported by remote monitoring platforms and digital training tools that make home-based treatment more accessible to eligible patients.

United States Dialysis Market Report Segmentation:

The United States Dialysis Market report provides a detailed segmentation analysis to help businesses identify key growth segments and evolving industry dynamics. The market is categorized based on type, product and services, and end user.

Type Insights:

• Hemodialysis: Hemodialysis, comprising conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis, forms the largest treatment type, using a machine and filter to clean the blood outside the body.
• Peritoneal Dialysis: Peritoneal dialysis, comprising continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD), is gaining traction as a home-based alternative that cleans the blood inside the body using a fluid that absorbs waste.

Product and Services Insights:

• Services: Dialysis services, including in-center and home-based treatment delivery, represent a core revenue stream for providers across the u.s. dialysis market.
• Equipment: Equipment, including dialysis machines, water treatment systems, and other devices, forms the technological backbone of dialysis delivery.
• Consumables: Consumables, including dialyzers, catheters, and other disposables, support the ongoing, recurring nature of dialysis treatment.
• Dialysis Drugs: Dialysis drugs support the management of complications associated with kidney failure and dialysis treatment.

End User Insights:

• In-Center Dialysis: In-center dialysis remains the dominant end-user setting, accounting for the majority of patients treated at dialysis facilities nationwide.
• Home Dialysis: Home dialysis is expanding as patients increasingly seek the convenience, flexibility, and comfort of at-home treatment supported by remote monitoring technologies.

Regional Insights:

• Northeast: The Northeast benefits from dense urban populations and a concentrated network of dialysis facilities and academic medical centers.
• Midwest: The Midwest continues to see steady demand for dialysis services, supported by an aging population and rising chronic disease prevalence.
• South: The South represents a significant share of dialysis demand, driven by elevated rates of diabetes and hypertension across the region.
• West: The West is expanding its dialysis infrastructure, supported by growing adoption of home dialysis and value-based kidney care models.

United States Dialysis Market: Recent News and Developments

• 2026: Fresenius Medical Care accelerated the rollout of its 5008X CAREsystem across the United States, reaching around 100 clinics and surpassing 100,000 treatments, while advancing its kinexus digital platform to support home dialysis programs through remote therapy monitoring and prescription management.
• August 2026: DaVita reported that approximately 16% of its patients dialyzed at home in 2025, reflecting continued expansion of its home dialysis programs and Kidney Smart education initiatives, including a Home Edition class offering modality-specific guidance to patients considering home-based treatment.

Challenges Impacting the United States Dialysis Market

The market faces challenges related to the high cost of dialysis equipment, consumables, and ongoing treatment, which can strain healthcare budgets and limit access for uninsured or underinsured patients.

Additionally, a shortage of nephrology professionals and trained dialysis staff in certain regions, along with reimbursement complexities tied to Medicare and private insurance coordination, continues to constrain the pace of market expansion.

Investment Opportunities in the United States Dialysis Market

The u.s. dialysis market presents compelling investment opportunities supported by its projected growth from USD 31,073.9 Million in 2025 to USD 44,117.0 Million by 2034. Home dialysis technologies, including portable and wearable devices, represent a high-value opportunity as providers work to expand access beyond traditional in-center settings.

The integration of artificial intelligence and remote monitoring platforms into dialysis care management is also creating new avenues for investment, as companies seek to improve treatment prediction, reduce complications, and support the growing population represented in questions like how many people are on dialysis in the united states.

Outlook of the United States Dialysis Market (2026-2034)

The outlook for the u.s. dialysis market is positive, supported by the rising prevalence of chronic kidney disease, continued technological innovation, and growing healthcare funding and insurance coverage. The market is projected to grow from USD 31,073.9 Million in 2025 to USD 44,117.0 Million by 2034 at a CAGR of 3.97%.

Continued expansion of home dialysis programs, the introduction of portable and AI-integrated dialysis machines, and the increasing number of dialysis centers providing easier access to treatment will be the defining trends shaping the u.s. dialysis market through 2034.

Key Players in the United States Dialysis Market

The u.s. dialysis market is served by a mix of established national providers and global medical technology companies competing on the basis of service network reach, product innovation, and expansion of home-based treatment options.

• DaVita Inc.: A leading provider of comprehensive kidney care services, DaVita operates a broad network of outpatient dialysis centers, hospital-based services, and home-based modalities, and reported that approximately 16% of its patients dialyzed at home in 2025 as part of its continued push to expand home hemodialysis and peritoneal dialysis access.
• Fresenius Medical Care: A global leader in dialysis products and services, Fresenius Medical Care accelerated the U.S. rollout of its 5008X CAREsystem in 2026, reaching around 100 clinics and surpassing 100,000 treatments, while expanding its kinexus digital platform to support home dialysis programs through remote monitoring and supply management.

Frequently Asked Questions (FAQs): United States Dialysis Market

1. What is the current United States dialysis market size?

The United States dialysis market size reached USD 31,073.9 Million in 2025 and is projected to reach USD 44,117.0 Million by 2034, growing at a CAGR of 3.97% during 2026-2034.

2. How many people are on dialysis in the United States?

According to the National Forum of ESRD Networks, dialysis facilities across the United States were treating 516,837 patients on dialysis as of March 2025, of whom 433,396 received in-center hemodialysis and 78,407 received dialysis at home.

3. What are the key drivers of the u.s. dialysis market?

Key drivers include the rising prevalence of chronic kidney disease, technological innovation in dialysis machines, increasing healthcare funding and insurance coverage, and the growing preference for home dialysis.

4. Which segment leads the United States dialysis market?

Hemodialysis leads the u.s. dialysis market by type, while in-center dialysis remains the dominant end-user setting, though home dialysis continues to expand as a growing share of overall treatment.

5. Who are the key players in the United States dialysis market?

Key players in the u.s. dialysis market include DaVita Inc. and Fresenius Medical Care, alongside other national and regional providers offering in-center and home-based dialysis services.

Author IMARC Group 

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

United States: +1-201971-6302